Provider review
Levers Health review
Prices "microdose" and "low-dose" as two different products, not one blurred tier.
Two named programmes with different goals and different prices — billed, in the microdose case, every other month.
Price as published
Semaglutide Microdose: 2-month program $246.00, billed and shipped every 2 months (the site states this as $123/month) · its Low-Dose program is quoted as low as $246/month shipping monthly · semaglutide program from $247 · tirzepatide program from $296
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Levers is unusually precise about a distinction the rest of this market blurs: a microdose programme and a low-dose programme are separate products here, with separate prices and separate stated purposes, and the product page says which is which. Consultation, shipping, supplies and unlimited clinical support are inside the programme price rather than billed alongside it, and the framing is longevity and metabolic balance rather than maximum loss — which is the frame most people arrive at a microdose in. Read the billing line, though, not the per-month one: the monthly figure is the site's own arithmetic on a charge that actually arrives every two months, and there is no monthly-billed microdose to choose instead. The page also attaches a weight-loss range to the microdose programme that no trial of sub-therapeutic dosing has ever produced.
The trade-off we would want you to read first
⚠ The $123/month figure is an amortisation the site does the arithmetic for — the actual charge is $246 every two months, and no monthly-billed microdose option is published, so the low headline is not a monthly bill
Who it suits, and who it does not
A good fit if
- You want a provider that treats a microdose and a low dose as genuinely different protocols
- You want consultation, supplies and clinical support inside one number rather than billed underneath it
- You are optimising for metabolic and longevity goals rather than a weight target
- You are comfortable being billed and shipped on a two-month cycle
Look elsewhere if
- You budget monthly: the advertised per-month figure is an amortisation, not a charge you will see
- You want a tirzepatide microdose specifically — the priced microdose option is the semaglutide one
- You take a published weight-loss range at face value; this one is not backed by any microdose trial
- You want the pharmacy or the prescribing clinician named before you order
How the programme works
A longevity-framed telehealth practice that does something almost no one else here does: it treats "Microdose" and "Low-Dose" as two distinct programs with different purposes and different prices, and says so on the product page. The microdose is sold as a two-month program billed and shipped every other month, with shipping, supplies, consultation and unlimited clinical support included in the figure. That is genuinely the cheapest low-dose structure verified on this board — but the headline number is an amortisation, not a bill you receive, and there is no monthly-billed microdose option at all.
At a glance
- Pricing structure
- Varies by dose, plan or tier
- Consult
- Included in the price
- Compounding
- Not publicly identified
- Labs
- Not required
- Dietitian support
- Not included
Strengths
- Draws an explicit line between a microdose program and a low-dose program, with different prices and different stated goals — a distinction the rest of this board blurs
- Consultation, shipping, supplies and unlimited clinical support are stated as included in the program price rather than billed alongside it
- The lowest verified cost-per-month for a named microdose program on this board, on the site's own arithmetic
- Cancel, pause or reschedule at any time, stated on the purchase option itself
- Longevity and metabolic framing rather than maximum-weight-loss marketing, which is the frame a microdoser is usually in
The other trade-offs
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- The microdose purchase option we could read is semaglutide; a tirzepatide microdose is referenced in customer reviews rather than published as its own priced option
- The page attaches a weight-loss figure to the microdose program — "sometimes up to 15 pounds" — which no randomized trial of sub-therapeutic dosing supports
- Neither the compounding pharmacy nor a named clinician appears on the public product page
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Levers Health is one of 32 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.